XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.3
CONSOLIDATED BALANCE SHEET - USD ($)
$ in Millions
Sep. 30, 2024
Dec. 31, 2023
Investments:    
Fixed maturities, available for sale, at fair value (net of allowance for credit losses: September 30, 2024 - $25.9 and December 31, 2023 - $42.9; amortized cost: September 30, 2024 - $25,246.4 and December 31, 2023 - $23,699.2) $ 23,724.7 $ 21,506.2
Equity securities at fair value 120.5 96.9
Mortgage loans (net of allowance for credit losses: September 30, 2024 - $16.5 and December 31, 2023 - $15.4) 2,372.7 2,064.1
Policy loans 133.3 128.5
Trading securities 217.4 222.7
Investments held by variable interest entities (net of allowance for credit losses: September 30, 2024 - $1.8 and December 31, 2023 - $3.1; amortized cost: September 30, 2024 - $258.8 and December 31, 2023 - $787.6) 250.1 768.6
Other invested assets 1,595.5 1,353.4
Total investments 28,414.2 26,140.4
Cash and cash equivalents - unrestricted 1,164.7 774.5
Cash and cash equivalents held by variable interest entities 80.6 114.5
Accrued investment income 276.2 251.5
Present value of future profits 165.7 180.7
Deferred acquisition costs 2,100.9 1,944.4
Reinsurance receivables (net of allowance for credit losses: September 30, 2024 - $3.0 and December 31, 2023 - $3.0) 3,906.7 4,040.7
Market risk benefit asset 96.4 75.4
Income tax assets, net 788.7 936.2
Assets held in separate accounts 3.3 3.1
Other assets 648.0 641.1
Total assets 37,645.4 35,102.5
Liabilities for insurance products:    
Policyholder account balances 17,240.5 15,667.8
Future policy benefits 12,179.6 11,928.2
Market risk benefit liability 1.0 7.4
Liability for life insurance policy claims 59.9 62.1
Unearned and advanced premiums 217.4 218.9
Liabilities related to separate accounts 3.3 3.1
Other liabilities 951.0 848.8
Investment borrowings 2,188.9 2,189.3
Borrowings related to variable interest entities 283.1 820.8
Notes payable – direct corporate obligations 1,832.9 1,140.5
Total liabilities 34,957.6 32,886.9
Commitments and Contingencies
Shareholders' equity:    
Common stock ($0.01 par value, 8,000,000,000 shares authorized, shares issued and outstanding: September 30, 2024 – 103,922,954; December 31, 2023 – 109,357,540) 1.0 1.1
Additional paid-in capital 1,715.9 1,891.5
Accumulated other comprehensive loss (1,116.0) (1,576.8)
Retained earnings 2,086.9 1,899.8
Total shareholders' equity 2,687.8 2,215.6
Total liabilities and shareholders' equity $ 37,645.4 $ 35,102.5